PTC Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.

About PTCT

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

CEO

Matthew B. Klein

CEOMatthew B. Klein

Employees

991

Employees991

Headquarters

Warren, New Jersey

HeadquartersWarren, New Jersey

Founded

1998

Founded1998

Employees

991

Employees991

PTCT Key Statistics

Market cap

6.54B

Market cap6.54B

Price-Earnings ratio

-33.73

Price-Earnings ratio-33.73

Dividend yield

—

Dividend yield—

Average volume

2.43M

Average volume2.43M

High today

$80.00

High today$80.00

Low today

$78.10

Low today$78.10

Open price

$79.35

Open price$79.35

Volume

2.76M

Volume2.76M

52 Week high

$87.50

52 Week high$87.50

52 Week low

$43.18

52 Week low$43.18

Stock Snapshot

As of today, PTC Therapeutics(PTCT) shares are valued at $78.98. The company's market cap stands at 6.54B, with a P/E ratio of -33.73.

On 2026-06-21, PTC Therapeutics(PTCT) stock moved within a range of $78.10 to $80.00. With shares now at $78.98, the stock is trading +1.1% above its intraday low and -1.3% below the session's peak.

Trading activity shows a volume of 2.76M, compared to an average daily volume of 2.43M.

Over the past 52 weeks, PTC Therapeutics(PTCT) stock has traded between a high of $87.50 and a low of $43.18.

PTCT News

TipRanks 3d

PTC Therapeutics Completes Major Convertible Notes Offering

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Simply Wall St 3d

PTC Therapeutics Stock Could Be 14% Undervalued After $500 Million Note Refinancing

PTC Therapeutics (PTCT) has drawn fresh attention after launching a $500 million private placement of 0% convertible senior notes due 2031, aimed at refinancing...

TipRanks 6d

PTC Therapeutics files to sell $500M of Convertible Senior Notes due 2031

PTC Therapeutics (PTCT) announced that it intends to offer $500M aggregate principal amount of Convertible Senior Notes due 2031 to qualified institutional buye...

Analyst ratings

79%

of 14 ratings

Buy

78.6%

Hold

14.3%

Sell

7.1%

People also own

Based on the portfolios of people who own PTCT. This list is generated using Robinhood data, and it’s not a recommendation.

AMD

Pfizer

Alibaba

Taiwan Semiconductor Manu…

Eli Lilly

Meta Platforms

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.